查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590810

胃食道逆流疾病治療設備市場：按產品類型、手術類型、手術類型、設備類型、劑型、給藥途徑和最終用戶 - 2025-2030 年全球預測

Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胃食道逆流治療設備市場價值為58.5億美元，預計2024年將達到66.5億美元，複合年成長率為13.66%，到2030年將達到143.5億美元，預計將達到1000萬美元。

胃食道逆流症 (GERD) 設備市場包括旨在診斷和治療 GERD 的醫療設備，GERD 是一種胃酸回流到食道，導致胃灼熱和胃酸逆流等症狀的疾病。這些醫療設備的需求源於由於生活方式改變、肥胖和飲食等因素導致胃食道逆流（GERD）盛行率不斷增加。應用範圍包括診斷內視鏡檢查、酸性暴露的 pH 監測、磁性括約肌增強和射頻消融，以滿足從輕度到重度逆流情況的患者需求。最終使用領域包括醫院、門診手術中心和專科診所，這些領域對微創解決方案的需求正在增加。關鍵的成長要素包括內視鏡手術的進步、對胃食道逆流症併發症的認知提高以及支持設備採用的醫療保健政策。由於設備準確性和患者舒適度方面的技術創新，以及醫療保健基礎設施正在發展的新興市場的地理擴張，市場機會正在擴大。為了抓住這些機會，公司應該專注於非侵入性診斷和治療方法的研究和開發、客製化設備設計以及全球採用的策略夥伴關係。然而，先進設備的高成本、嚴格的監管核准以及藥物和生活方式改變等替代治療方法的可用性可能會限制其市場的廣泛使用。創新可以針對開發具有成本效益且患者友好的診斷工具，以及開發用於胃食道逆流症監測解決方案的人工智慧和機器學習。由於市場競爭激烈，並且公司專注於產品差異化和患者治療結果，因此公司不斷創新並滿足醫療保健提供者的需求非常重要。開拓有關 GERD 管理的教育舉措可以提高最終用戶的意識、提高市場滲透率並促進整個 GERD 裝置領域的成長。

主要市場統計
基準年[2023] 58.5億美元
預測年份 [2024] 66.5億美元
預測年份 [2030] 143.5億美元
複合年成長率（%） 13.66%

市場動態：快速發展的胃食道逆流治療設備市場的關鍵市場洞察

胃食道逆流病治療設備市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界老化人口增加
    • 肥胖人口不斷增加，對手術的偏好日益增加
    • 診斷中心和私人診所的招募人數迅速增加
  • 市場限制因素
    • 質子幫浦阻斷劑等替代藥物的可用性
  • 市場機會
    • 活性化技術創新力道及新產品推出進場
    • 自我治療和疾病意識的持續趨勢
  • 市場挑戰
    • 設備接受度下降，缺乏標準監管核准

波特五力：駕馭胃食道逆流治療設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對胃食道逆流症治療器械市場的影響

外部宏觀環境因素在塑造胃食道逆流疾病治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解胃食道逆流症治療器材市場競爭狀況

胃食道逆流治療設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣胃食道逆流治療設備市場供應商績效評估

FPNV定位矩陣是評估胃食道逆流治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪胃食道逆流症治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對胃食道逆流治療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地人口老化不斷加劇
      • 肥胖人口增加和對手術的偏好增加
      • 診斷中心和私人診所的採用率迅速增加
    • 抑制因素
      • 質子幫浦抑制劑等替代藥物的可用性
    • 機會
      • 強而有力的創新並向市場推出新的先進產品
      • 自我藥療和疾病意識的持續趨勢
    • 任務
      • 設備接受度下降，缺乏標準監管核准
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章胃食道逆流症治療設備市場：依產品類型

  • 診斷設備
  • 食道鏡和胃照相機
  • 胃底折疊術器械
  • 測壓系統
  • PH監測系統
  • 射頻消融術裝置
  • 括約肌增強裝置
  • 治療設備
  • 超音波外科腔內吻合器

第7章胃食道逆流症治療設備市場（依手術類型）

  • 診斷程序
  • 胃底折疊術
  • 磁括約肌增強術
  • 射頻熱消融

第8章依手術類型分類的胃食道逆流治療設備市場

  • 侵入性的
    • 山貓逆流症管理
    • Medgas超音波外科內視鏡吻合器
  • 非侵入性
    • 腔內胃造口術
    • 內視鏡折疊系統
    • 埃索菲克斯
    • 有機玻璃聚甲基丙烯酸甲酯微球
    • 史特雷塔

第9章胃食道逆流症治療設備市場（依設備類型）

  • Bravo 逆流測試系統
  • DigiTrapper回流偵測系統
  • LINX管理系統
  • MUSE-Medigus超音波外科內視鏡吻合器
  • 斯特雷塔療法

第10章胃食道逆流症治療器材市場（按劑型）

  • 液體
  • 固體的

第11章胃食道逆流症治療設備市場：依給藥途徑

  • 口服
  • 胃腸外的

第12章胃食道逆流症治療設備市場：依最終使用者分類

  • 政府
  • 醫院
  • 醫務工作者

第13章北美和南美胃食道逆流症治療器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太地區胃食道逆流症治療器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章歐洲、中東和非洲胃食道逆流症治療器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Addex Pharmaceuticals Ltd.
  • Aros Pharma ApS
  • AstraZeneca PLC
  • CR Bard, Inc.
  • Eisai Co., Ltd.
  • EndoGastric Solutions, Inc.
  • Frost & Sullivan Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • MediGus Ltd.
  • Olympus Corporation
  • PENTAX Europe GmbH
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • The Procter & Gamble Company
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market was valued at USD 5.85 billion in 2023, expected to reach USD 6.65 billion in 2024, and is projected to grow at a CAGR of 13.66%, to USD 14.35 billion by 2030.

The Gastroesophageal Reflux Disease (GERD) Devices market encompasses a range of medical devices aimed at diagnosing and treating GERD, a condition characterized by the backflow of stomach acid into the esophagus causing symptoms like heartburn and acid reflux. The necessity of these devices lies in the increasing prevalence of GERD, driven by factors such as lifestyle changes, obesity, and dietary habits. Their application extends across diagnostic endoscopy, pH monitoring for acid exposure, magnetic sphincter augmentation, and radiofrequency ablation, addressing patient needs from mild to severe reflux symptoms. End-use segments include hospitals, ambulatory surgical centers, and specialty clinics where the demand for minimally invasive solutions is rising. Key growth factors include advancements in endoscopic procedures, increased awareness of GERD complications, and supportive healthcare policies favoring device adoption. Market opportunities are expanding with technological innovations in device precision and patient comfort, and geographic expansion in emerging markets with rising healthcare infrastructure. To capture these opportunities, companies should focus on R&D in non-invasive diagnostics and treatment methods, customized device designs, and strategic partnerships to widen global outreach. However, the market faces limitations due to high costs of advanced devices, stringent regulatory approvals, and the availability of alternative treatment methods like medication and lifestyle modification, which might inhibit device adoption. Innovation could be directed towards developing cost-effective, patient-friendly diagnostic tools and exploring AI and machine learning for GERD monitoring solutions. The market is competitive with players focusing on product differentiation and patient outcomes, making it crucial for companies to continuously innovate and align with healthcare provider needs. Developing educational initiatives around GERD management could enhance end-user awareness and drive market penetration, fostering overall growth in the GERD devices sector.

KEY MARKET STATISTICS
Base Year [2023] USD 5.85 billion
Estimated Year [2024] USD 6.65 billion
Forecast Year [2030] USD 14.35 billion
CAGR (%) 13.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising aging population across the world
    • Growing obese population and their preference for surgeries
    • Surge in adoption among diagnostic centers and private clinics
  • Market Restraints
    • Availability of alternative such as proton pump inhibitors
  • Market Opportunities
    • Robust innovation and launch of new advanced products in the market
    • Ongoing trend of self-medication and awareness of the disease
  • Market Challenges
    • Decreased acceptability of devices an dearth of standard regulatory approval

Porter's Five Forces: A Strategic Tool for Navigating the Gastroesophageal Reflux Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastroesophageal Reflux Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastroesophageal Reflux Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastroesophageal Reflux Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastroesophageal Reflux Disease Devices Market

A detailed market share analysis in the Gastroesophageal Reflux Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastroesophageal Reflux Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastroesophageal Reflux Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastroesophageal Reflux Disease Devices Market

A strategic analysis of the Gastroesophageal Reflux Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage

This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.
  • Based on Procedure Type, market is studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.
  • Based on Surgery Type, market is studied across Invasive and Non-Invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-Invasive is further studied across Endocinch Endolumminal Gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas Poly-Methyl-Methacrylate Microspheres, and Stretta.
  • Based on Device Type, market is studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, and Stretta Therapy.
  • Based on Dosage Form, market is studied across Liquid and Solid.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on End-User, market is studied across Government, Hospitals, and Medical Practitioners.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising aging population across the world
      • 5.1.1.2. Growing obese population and their preference for surgeries
      • 5.1.1.3. Surge in adoption among diagnostic centers and private clinics
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative such as proton pump inhibitors
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust innovation and launch of new advanced products in the market
      • 5.1.3.2. Ongoing trend of self-medication and awareness of the disease
    • 5.1.4. Challenges
      • 5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Devices
  • 6.3. Esophagoscopes & Gastroscopes
  • 6.4. Fundoplication Devices
  • 6.5. Manometry System
  • 6.6. PH Monitoring System
  • 6.7. Radiofrequency Ablation Devices
  • 6.8. Sphincter Augmentation Devices
  • 6.9. Treatment Devices
  • 6.10. Ultrasonic Surgical Endostapler

7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Diagnostic Procedures
  • 7.3. Fundoplication Procedures
  • 7.4. Magnetic Sphincter Augmentation
  • 7.5. Radiofrequency Thermal Ablation

8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type

  • 8.1. Introduction
  • 8.2. Invasive
    • 8.2.1. Linx Reflux Management
    • 8.2.2. Medigus Ultrasonic Surgical Endostapler
  • 8.3. Non-Invasive
    • 8.3.1. Endocinch Endolumminal Gastroplication
    • 8.3.2. Endoscopic Plicator System
    • 8.3.3. EsophyX
    • 8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
    • 8.3.5. Stretta

9. Gastroesophageal Reflux Disease Devices Market, by Device Type

  • 9.1. Introduction
  • 9.2. Bravo Reflux Testing System
  • 9.3. Digitrapper reflux testing system
  • 9.4. LINX Management System
  • 9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
  • 9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form

  • 10.1. Introduction
  • 10.2. Liquid
  • 10.3. Solid

11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, by End-User

  • 12.1. Introduction
  • 12.2. Government
  • 12.3. Hospitals
  • 12.4. Medical Practitioners

13. Americas Gastroesophageal Reflux Disease Devices Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addex Pharmaceuticals Ltd.
  • 2. Aros Pharma ApS
  • 3. AstraZeneca PLC
  • 4. C. R. Bard, Inc.
  • 5. Eisai Co., Ltd.
  • 6. EndoGastric Solutions, Inc.
  • 7. Frost & Sullivan Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. KARL STORZ SE & Co. KG
  • 10. MediGus Ltd.
  • 11. Olympus Corporation
  • 12. PENTAX Europe GmbH
  • 13. Pfizer Inc.
  • 14. Takeda Pharmaceutical Company Limited
  • 15. The Procter & Gamble Company

LIST OF FIGURES

  • FIGURE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES & GASTROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 250. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 251. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 259. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 268. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 277. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE,